Illumina launches whole-genome sequencing kit for cancer research
Go back to Illumina launches whole-genome sequencing kit for cancer research| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 164.18 +2.80 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.38 | 52 Week High | $196.47 | |||
| Open | $160.60 | 52 Week Low | $127.10 | |||
| Day High | $166.63 | P/E | 182.42 | |||
| Day Low | $159.98 | EPS | $0.90 | |||
| Volume | 470,900 | |||||

